← Back to Clinical Trials
Recruiting NCT07547566

NCT07547566 Recovery After Fatigue in Young Athletes: Comparison Between TECAR Therapy and Cycle Ergometer"

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07547566
Status Recruiting
Phase
Sponsor Maimónides Biomedical Research Institute of Córdoba
Condition Muscle Fatigue
Study Type INTERVENTIONAL
Enrollment 48 participants
Start Date 2026-04
Primary Completion 2026-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Tecar therapy (capacitive mode)Active recovery using cycle ergometer

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 48 participants in total. It began in 2026-04 with a primary completion date of 2026-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to compare two recovery methods after fatigue in young athletes. It aims to find out if tecar therapy (TECAR) or cycle ergometer exercise can improve recovery after intense physical activity and help athletes return to their normal performance more quickly. The main questions it aims to answer are: Does TECAR or cycle ergometer improve physical performance after fatigue? Do these methods reduce muscle pain and soreness after fatigue? Researchers will compare TECAR with active recovery using a cycle ergometer to see which method is more effective. Participants will: Perform a series of jumps to induce fatigue Be randomly assigned to one of the recovery methods Complete physical tests before and after fatigue Undergo simple measurements of muscle condition and pain Report their level of effort and muscle soreness

Eligibility Criteria

Inclusion Criteria: * Adults aged 18 years or older * Engaging in regular physical activity * Experience with sports involving jumping or plyometric exercises Exclusion Criteria: * Performed intense physical exercise within 24 hours before the study * Planned to perform intense physical exercise within 24 hours after the study * Presence of muscle soreness at the beginning of the study * Musculoskeletal injury in the previous 6 months

Contact & Investigator

Central Contact

Sandra Alcaraz Clariana, PhD PT

✉ m72alcls@uco.es

📞 +34625434043

Principal Investigator

Sandra Alcaraz Clariana, PhD PT

PRINCIPAL INVESTIGATOR

Maimonides Biomedical Research Institute of Cordoba (IMIBIC). Department of Nursing, Pharmacology and Physical Therapy, Faculty of Medicine and Nursing, University of Córdoba, Córdoba, Spain;

Frequently Asked Questions

Who can join the NCT07547566 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Muscle Fatigue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07547566 currently recruiting?

Yes, NCT07547566 is actively recruiting participants. Contact the research team at m72alcls@uco.es for enrollment information.

Where is the NCT07547566 trial being conducted?

This trial is being conducted at Córdoba, Spain.

Who is sponsoring the NCT07547566 clinical trial?

NCT07547566 is sponsored by Maimónides Biomedical Research Institute of Córdoba. The principal investigator is Sandra Alcaraz Clariana, PhD PT at Maimonides Biomedical Research Institute of Cordoba (IMIBIC). Department of Nursing, Pharmacology and Physical Therapy, Faculty of Medicine and Nursing, University of Córdoba, Córdoba, Spain;. The trial plans to enroll 48 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology